Polymyxin B

Polymyxin B is an antibiotic used in Microbiology to treat some Gram-negative infections, especially in topical skin and eye treatments. It kills bacteria by binding to the outer membrane and breaking it apart.

What is Polymyxin B?

Polymyxin B is a membrane-targeting antibiotic used in Microbiology to treat certain Gram-negative bacterial infections, especially when the infection is on the skin or in the eye. It is one of the classic drugs students see when they study how antibiotics attack bacterial cell structures instead of just slowing growth.

Its target is the outer membrane of Gram-negative bacteria. That outer layer contains lipopolysaccharides, often shortened to LPS, which help protect the cell from outside threats. Polymyxin B binds to those LPS molecules and destabilizes the membrane, so the bacterial cell leaks contents and dies.

That mechanism is why Polymyxin B is especially associated with organisms like Pseudomonas aeruginosa, a tough Gram-negative pathogen that can show up in skin and eye infections. If a bacterium has that outer membrane structure, Polymyxin B has a place to bind. If it does not, the drug is much less useful, which is why it is not a broad treatment for every bacterial infection.

In practice, Polymyxin B is often used in topical products such as ointments and eye drops. That makes sense because the drug can be very toxic if given systemically, especially to the kidneys. So when you see it in Microbiology, think about both mechanism and route of use, not just the name of the antibiotic.

It is also a good example of how combination therapy can show up in treatment plans. Pairing antibiotics can widen coverage and may reduce the chance that resistant bacteria survive. Even though resistance to Polymyxin B is relatively uncommon compared with some other antibiotics, the drug still needs to be used carefully because once membrane-targeting antibiotics stop working, treatment choices get narrower fast.

Why Polymyxin B matters in MICROBIO

Polymyxin B shows up in Microbiology because it connects bacterial structure to treatment choice. If you know that it targets the outer membrane of Gram-negative bacteria, you can explain why it works on some pathogens and not others. That kind of reasoning comes up constantly when you connect a microbe’s cell wall or envelope to the drug used against it.

It also fits the skin and eye infection unit well. A case involving conjunctivitis, keratitis, or an infected wound may mention a topical antibiotic, and Polymyxin B is one of the names that should ring a bell. Seeing the drug in the context of Pseudomonas aeruginosa helps you link a pathogen to a realistic clinical use.

This term is also useful for comparing therapy routes. The fact that it is commonly topical because of nephrotoxicity is a detail that can explain why a treatment is applied to the eye or skin instead of given by mouth or IV. That is the kind of detail instructors like when they ask you to justify a treatment choice or interpret a case.

How Polymyxin B connects across the course

Gram-negative bacteria

Polymyxin B is aimed at Gram-negative bacteria because they have an outer membrane with LPS, the structure the drug binds to. If you forget that membrane difference, the drug can seem arbitrary. This connection helps you predict why some pathogens are susceptible and why Gram-positive bacteria are not the main target.

Pseudomonas aeruginosa

This bacterium is a classic organism tied to Polymyxin B because it can cause stubborn skin and eye infections. When a case names Pseudomonas, you should think about resistant Gram-negative treatment options and topical therapy. It is a good example of why membrane-active antibiotics stay clinically relevant.

bacterial keratitis

Polymyxin B may appear in eye-drop treatments for bacterial keratitis when the infection involves susceptible Gram-negative organisms. The connection matters because keratitis can threaten vision, so treatment choices are specific and fast. In a lab or case question, the route of use often matters as much as the drug name.

Neomycin

Neomycin is often paired with Polymyxin B in topical combination products. That pairing broadens antibacterial coverage and helps explain why a single ointment can work against more than one type of skin or eye pathogen. If you see both names together, think combination therapy rather than a single-drug mechanism.

Is Polymyxin B on the MICROBIO exam?

A quiz item or case question may give you a skin or eye infection and ask which antibiotic fits a Gram-negative pathogen. The move is to connect the organism to the outer membrane target, then decide whether Polymyxin B makes sense as a topical drug. If the prompt mentions Pseudomonas aeruginosa, eye drops, or an ointment for a localized infection, that is a strong clue.

You may also need to explain why the drug is not used systemically. The correct reasoning is not just that it works, but that toxicity limits how it is given. In a short-answer response, name the target, the type of bacteria affected, and the route of administration. That shows you can trace mechanism to treatment choice instead of memorizing a drug list.

Polymyxin B vs Neomycin

These are often confused because they appear together in topical antibiotic products. Polymyxin B mainly attacks the outer membrane of Gram-negative bacteria, while neomycin has a different antibacterial target and broader combination use in skin and eye preparations. If a question asks what Polymyxin B does, focus on membrane disruption and LPS binding.

Key things to remember about Polymyxin B

• Polymyxin B is a topical antibiotic used in Microbiology to treat certain Gram-negative infections, especially on the skin and in the eye.

• It works by binding to lipopolysaccharides in the outer membrane of Gram-negative bacteria and breaking that membrane down.

• Pseudomonas aeruginosa is a common organism linked to Polymyxin B because it can cause stubborn skin and eye infections.

• The drug is often given as an ointment or eye drop because systemic use can cause serious kidney toxicity.

• Combination therapy with other antibiotics can widen coverage and help slow the rise of resistance.

Frequently asked questions about Polymyxin B

What is Polymyxin B in Microbiology?

Polymyxin B is an antibiotic that targets Gram-negative bacteria by disrupting the outer membrane. In Microbiology, you usually see it in the context of skin and eye infections, especially topical treatment. It is a good example of a drug that works because of bacterial envelope structure.

How does Polymyxin B work?

It binds to lipopolysaccharides in the outer membrane of Gram-negative bacteria. That weakens the membrane, causes leakage, and kills the cell. The mechanism is why it is effective against bacteria with that outer layer but not against organisms that lack it.

Why is Polymyxin B used topically?

Polymyxin B can be nephrotoxic if it is used systemically, so it is usually reserved for ointments or eye drops. Topical use lets it treat local skin or eye infections while reducing the risk of serious side effects. That route is a big part of how the drug is applied clinically.

Is Polymyxin B the same as Neomycin?

No. They are different antibiotics, although they are sometimes combined in topical products. Polymyxin B is known for membrane damage in Gram-negative bacteria, while Neomycin works through a different antibacterial mechanism. If a question mentions both, think combination therapy.